Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review).

Author: GhasemiAsghar, JediS, KhalifiS

Paper Details 
Original Abstract of the Article :
Diabetes is one of the five leading causes of death in the world, with type 2 diabetes occurring more frequently than type 1. Management of diabetes without side effects is still a challenge and therefore new strategies need to be examined. Because of difficulties in human research, animal models of...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1556/APhysiol.101.2014.4.2

データ提供:米国国立医学図書館(NLM)

Streptozotocin-Nicotinamide Model: A Valuable Tool for Type 2 Diabetes Research

Type 2 diabetes is a growing global health concern, much like the expanding desert sands. This study reviews the streptozotocin-nicotinamide-induced rat model of type 2 diabetes, a valuable tool for studying this complex disease. The study aimed to assess the advantages and disadvantages of this model in relation to human diabetes research.

A Versatile Model for Diabetes Research

The study highlights the streptozotocin-nicotinamide model as a widely used and versatile tool for studying type 2 diabetes in rats. The model mimics key features of human type 2 diabetes, providing researchers with a valuable platform for investigating potential therapies and understanding the disease's pathogenesis.

Understanding and Managing Diabetes

Diabetes, much like a desert ecosystem, requires a delicate balance to maintain health. The study underscores the importance of animal models in advancing diabetes research. The streptozotocin-nicotinamide model offers a valuable platform for exploring new treatments and strategies for managing this complex disease.

Dr.Camel's Conclusion

This research provides a comprehensive overview of the streptozotocin-nicotinamide-induced rat model of type 2 diabetes. The study underscores the model's value in advancing diabetes research and its potential to contribute to the development of new and effective therapies.

Date :
  1. Date Completed 2015-03-11
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

25532953

DOI: Digital Object Identifier

10.1556/APhysiol.101.2014.4.2

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.